Barely Significant
← all phrases

of borderline significance

483 sentences · 483 papers · 11,068 search hits before verification

In the literature

of borderline significancep = 0.76615.3× alpha
VBI occurrence was associated with a subsequent anti-S IgG titer increase of 0.13% per day (-0.01% to 0.27%; p = 0.076), although this association was of borderline significance, compared to stable anti-S IgG titers in participants without VBI (0.03% increase per day during day 181–360 [-0.19% to 0.26%]; p = 0.766).
of borderline significanceP >.9919.8× alpha
Secondary Outcomes For total stress measured using the PST, we observed a reduction in stress in the MR group relative to the waitlist control group that was of borderline significance (β=–.002; SE 0.001; P >.99; Table 4 ); however, no effect of the MR intervention was observed for stress as measured using the PSS ( P =.18).
Conversely, differences in survival favoring M+/without PD patients exposed to olaparib were only of borderline significance ( n = 73, of whom 51 received platinum‐based first‐line chemotherapy; Figure S2A and Table S1 ) and did not significantly differ in patients who received olaparib in its current indication (first‐line maintenance in patients not progressing after platinum‐based chemotherapy, n = 60; Figure S2B ).
Nevertheless, while no significant correlation was observed for TWIST1, a significant inverse correlation was observed between 2′Ome levels at the 28S_Um2402 rRNA site and the expression of ZEB1, similar trend of borderline significance being observed with ZEB2 overexpression (Fig. 5C – E ).
When the model was adjusted for the benchmark biomarker NT‐proBNP, CERT2 was no longer independently related to CV‐death and it's relation with MACE was of borderline significance, while a strong association for Ln‐transformed NT‐proBNP could be observed: 1.95 (1.69–2.26) and 1.76 (1.55–2.00), respectively for CV death and MACE.
However, by the year of diagnosis, there was a 57%–70% increase in not starting TB treatment among those diagnosed with TB in 2021/22 as compared with 2020/19, and a significant drop in TB treatment coverage for males and of borderline significance for females diagnosed in 2021/22 as compared with 2019.
Concerning our current data, although the levels of 7α/β- and 16α-hydroxy-steroids did not show a significant trend toward changes after treatment with anti-MS drugs, the SMRs of 7α/β- and 16α-hydroxy-steroids to the parent steroids suggested a reduction in the activities of the enzymes catalyzing their synthesis (CYP7B1, CYP3A4, and CYP3A7) of borderline significance despite the low number of corresponding SMRs ( n = 8).